The association of pyruvate kinase muscle type (PKM) with survival of cancer patients 36 is controversial. Here, we focus on different transcripts of PKM and investigate the 37 association between their mRNA expression and the clinical survival of the patients in 38 25 different cancers. We find that the transcript encoding PKM2, and three other 39 functional transcripts are prognostic in multiple cancers. Our integrative analysis shows 40 that the functions of these four transcripts are highly conservative in different cancers. 41
Introduction 52
Pyruvate kinase muscle type (PKM) is the most-studied isoform of pyruvate kinase and 53 catalyzes the final step in glycolysis 1 . It is one of the key mediators of the Warburg 54 effect and plays a pivotal role in controlling tumor metabolism. It has been reported 55 that the mRNA and protein expression of PKM is strongly associated with the survival 56 of cancer patients, but the direction of the correlation was contradictory since both 57 activation and inhibition of this enzyme have been suggested for effective treatment of 58 the cancer patients 2 . In the Human Pathology Atlas 3 , high expression of PKM is 59 significantly (log-rank p-value<0.05) associated with the unfavorable prognoses in liver 60 hepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), head and neck 61 squamous cell carcinoma (HNSC) and lung adenocarcinoma (LUAD) whereas it is also 62 associated with favorable prognoses in kidney renal clear-cell carcinoma (KIRC), skin 63 cutaneous melanoma (SKCM), stomach adenocarcinoma (STAD) and thyroid 64 carcinoma (THCA). Thus, mRNA expression of PKM has ambiguous indication of 65 patients' survival in different cancer-types. 66
67
The oncological roles of differentially spliced transcripts of PKM including PKM1 and 68 PKM2, which are mutually exclusive exons 9 and 10 4 , have been previously 69 investigated. It has been reported that overexpression of PKM1/2 isoforms promotes 70 tumorigenesis or induces poor prognoses of patients in multiple cancers [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] whereas 71 PKM1 expression in place of PKM2 inhibits tumor cell proliferation 18, 19 . Moreover, it 72 has been reported that methylation or deletion of PKM2 promotes tumor progression 73 in liver cancer, breast cancer and medulloblastoma [20] [21] [22] [23] . Therefore, the function of 74 alternative splicing products of PKM in tumor oncogenesis and progression remains 75
controversial. 76 77
Due to alternative splicing, there are 14 known isoforms of the PKM, of which PKM1 78 and PKM2 are two major isoforms. To our knowledge, the roles of other protein 79 products of PKM apart from PKM1 and PKM2 have not been studied. In this study, we 80 and similar scenarios could be found in CESC, PAAD, BRCA and colon carcinoma 122
(COAD). 123 124

Biological functions of the PKM transcripts 125
We identified four different transcripts of PKM including ENST00000335181, 126 ENST00000561609, ENST00000389093 and ENST00000568883 which exhibited 127 opposite prognostic effect in multiple cancer types. Hence, we investigated whether 128 this opposite trend is also observed at the functional level in all cancer types. To 129 systematically identify the functions of the four prognostic PKM transcripts, we 130 identified the differentially expressed genes (DEGs) between patients with the top 25% 131 high expression and bottom 25% low expression of each transcript in all cancers (FDR 132 < 1.0e-05). We performed a gene ontology (GO) enrichment analysis using the DEGs 133 driven by each transcript and summarized the results of the enriched GO terms for all 134 transcripts in all cancer types (FDR < 0.001, Figure 1B and Table S3 ). As shown in 135 Figure 1B , if a GO term is enriched with DEGs in multiple cancers, the directionality of 136 the DEGs often follows the same direction. For example, as shown in Figure 1B , the 137 DEGs identified by comparing high and low expression of ENST00000335181 is 138 enriched in extracellular matrix organization pathway in 16 cancers and are always 139 associated with the upregulated genes. Our analysis indicated that although the 140 prognostic effect of each transcript is different, the associated biological functions are 141 conserved in different cancers. 142 143 First, we focused on GO terms that are consistently enriched in more than 10 cancers 144 and conservatively associated with the corresponding transcript. We investigated the 145 enriched GO terms associated with ENST00000335181 encoding PKM2. As shown in 146 Figure 1B , glycolytic process, hypoxia response, NADH regeneration pathways are 147 enriched with upregulated genes in patients with high expression of 148 ENST00000335181. This is expected since it reflects the key enzymatic role in 149 glycolysis of PKM2. On the other hand, ATP synthesis, mitochondrial respiratory 150 process, oxidative phosphorylation pathways are enriched with downregulated genes, 151 which probably indicated the shift from oxidative phosphorylation to glycolysis that is 152 well known as the Warburg effect in cancer. Moreover, the upregulated genes were 153 also enriched in pathways associated with the cell morphology such as cell motility, 154 cell migration, cell adhesion and cell junction pathways. These could be linked to the 155 tumorigenesis role of PKM2 7, 8, 26, 27 . Interestingly, several RNA processing related 156 pathways, translational initiation pathway and pathways related to protein localization 157 were also enriched with down-regulated genes in cancer patients with high expression 158 of ENST00000335181. These pathways were rarely associated with the biological 159 function of PKM in previous studies and appeared as commonly enriched GO terms in 160 the same analysis for other three transcripts. Hence, studying alternative splicing 161 processes of PKM in different cancers provided further understanding about the role 162 of PKM in cancer progression. 163 164 Second, we investigated the function of other three transcripts of PKM whose functions 165
have not been known. We found that many of the enriched GO terms associated with 166 these three transcripts are similar to the GO terms associated with ENST00000335181 167 ( Figure 1B) . However, the GO terms associated with the ENST00000561609 followed 168 the same direction with those of ENST00000335181, of which followed the opposite 169 direction with the GO terms associated with both ENST00000389093 and 170 ENST00000568883. In total, 27 different GO terms, e.g. oxidative phosphorylation, 171 translational initiation and RNA catabolic processes, are enriched with genes that are 172 downregulated with both ENST00000335181 and ENST00000561609, and genes that 173 are upregulated with both ENST00000389093 and ENST00000568883. 174
175
We also compared the DEGs identified by comparing high and low expression of each 176 transcript and observed similar results based on the directionality and overlap of the 177 DEGs. For instance, in KIRC, we identified 3162 and 6592 DEGs when comparing the 178 high and low expression of ENST00000335181 and ENST00000561609, which both 179 exhibited favorable prognostic indications, respectively. We found that the two sets of 180 DEGs has a significant overlap (n = 2010; hypergeometric distribution test, p < 1.11e-181 16) and the concordance score of these overlapped genes (using directionality of the 182 DEGs) is 99.06%. We also identified 6541 and 6885 DEGs when comparing the high 183 and low expression of ENST00000389093 and ENST00000568883 transcript pair, 184 which both exhibited unfavorable prognostic effect in KIRC, respectively. Notably, we 185 found that the overlap between the DEGs of the transcripts is 5469 (hypergeometric 186 distribution test, p < 1.11e-16) and the concordance score is 100%. On the other hand, 187
we investigated the overlap between DEGs associated with the transcripts exhibiting 188 the opposite prognostic effect and found that there is no statistically significant overlap. 189
For instance, in KIRC, the concordance score of the overlapped DEGs between 190 transcripts with opposite prognostic indications were between 0.10% and ~20% (Table  191 S4). Similar scenarios were also observed in CESC, PAAD, BRCA, and COAD ( We performed a survival analysis for these four transcripts in 100 KIRC patients 198 involved in an independent Japanese study 28 . As shown in Figure 2A We found that the number of overlapped DEGs identified for ENST00000561609, 227 ENST00000389093 and ENST00000568883 are 1370, 1499 and 1449 228 (hypergeometric distribution test, p < 1.11e-16) and the concordance scores between 229 the cohorts are 100%, 99.93% and 99.86%, respectively (Table S9 ). Our analysis 230 indicated that the biological functions associated with each of these three transcripts 231 are highly conserved in independent KIRC cohorts. However, we found that the 232 number of overlapping DEGs identified with the transcript ENST00000335181 in both 233 cohorts is relatively small (n = 546; hypergeometric distribution test, p ≈ 1) and the 234 concordance score is 75.46%, which also indicates the differences between the two 235 cohorts. Such differences may be explained by the dietary and geographical 236 differences between the two independent cohorts. 237
238
Combined prognostic signature for KIRC 239
Based on the highly conserved prognostic effects of the PKM transcripts in two 240 independent KIRC cohorts, there is likely to be different molecular subtypes among 241 KIRC patients with opposite expression patterns of the transcripts highlighted in this 242 study. Thus, we extracted a prognostic signature based on the expression value of 243 these four transcripts (see method). In brief, if more than half of the transcripts indicates 244 an unfavorable prognosis, the patient is classified as high-risk and otherwise as low-245 risk. Using this rule, we observed significantly different overall survival (log-rank p < 246 0.01) between high-and low-risk groups in both TCGA and Japanese KIRC cohorts as 247 shown in Figure 2B . 248
249
To investigate whether these two molecular subtypes identified in both cohorts 250 exhibited similar biological differences, we extracted the top 20% most significant 251 DEGs (n = 2694) between high-risk and low-risk groups in the TCGA and Japanese 252 cohorts. The two lists of DEGs had significant overlap (n = 1516; hypergeometric 253 distribution test, p < 1.11e-16) and the concordance score was 100%. In addition, we 254 identified 57 and 74 GO terms that are significantly enriched with upregulated genes 255 (FDR < 1.0e-05) in the high-risk group of the TCGA and Japanese cohorts, respectively 256 ( Figure 2C , Table S10 ). Interestingly, we found that 55 of these enriched GO terms are 257 common in both cohorts and the molecular subtypes identified by our analysis have 258 consistent biological differences. Moreover, 26 of the 27 GO terms that are significantly 259 associated with the four transcripts (shown in Figure 1B , e.g. oxidative 260
phosphorylation, translational initiation and RNA catabolic process) are also among 261 the overlapped enriched GO terms, which further indicated that the molecular subtypes 262 are functionally related to the four key transcripts of PKM identified in this study. 263 264
Discovery of the protein products of the prognostic transcripts 265
To investigate and compare the protein products of the three novel transcripts including 266 ENST00000561609, ENST00000389093 and ENST00000568883, whose functions 267 were previously unknown compared to the function of ENST00000335181 (encoding 268 PKM2), we first aligned their amino acid (AA) sequences (Table S11 ). We observed 269 that ENST00000335181 has the longest AA sequence with 531aa, followed by the 270 protein products of ENST00000561609, ENST00000389093, and 271 ENST00000568883, which are 485aa, 457aa, and 366aa, respectively. As shown in 272 Figure 3A , we found that proteins of ENST00000389093 and ENST00000568883 miss 273 a part of the A1 and B domains (59-132aa and 41-205aa) in PKM2, which may affect 274 the formation of dimer 29 . We also found that the protein product of ENST00000561609 275 is shorter than PKM2, missing amino acid residues 486-531aa from PKM2 which is a 276 part of the C-domain participating in the formation of tetramer 29 . This implicated that 277 the protein encoded by ENST00000561609 may have no tetrameric formation. In 278 addition, there is part of the AA sequence, 389-433aa, of the protein product of 279 ENST00000561609 and ENST00000568883 resembles PKM1 protein rather than 280 PKM2. In this part, K433 is the fructose 1,6-bisphosphate (FBP) binding site in PKM2, 281 which activates the association of monomer to form the tetrameric 30 . However, PKM1 282 does not bind FBP due to AA difference at the FBP binding pocket and it naturally 283 exists as a stable tetramer that has high constitutive activity 31 . In addition, all protein 284 products of the three transcripts have K270, which is the active site, binding to 285
phosphoenolpyruvate (PEP). 286 287
Furthermore, we constructed the homology models of ENST00000561609, 288 ENST00000389093 and ENST00000568883 to obtain the protein structure 289 information. When compared to the PKM2 structure, we found that the 290 ENST00000389093 structure is missing the catalytic site for ADP binding (59-132aa) 291 and several AA residues, including R73, Q75, H78, G79, H80, E118, and R120 from 292 the missing part are in close contact with ADP ( Figure 3B ). Instead, the 293 ENST00000389093 structure forms a newly ordered loop going straight through the 294 ADP binding site, and whether this loop is able to coordinate the ADP binding is still 295 unknown. On the other hand, we observed that the PEP and the FBP binding site in 296 ENST00000389093 structure is fully maintained as in the PKM2 structure, and the 297 tetramer binding interface is kept the same as in PKM2 structure. The protein product 298 of ENST000000561609 shares the exact the same AA sequence as in PKM1, but 299 missing the AAs from 486 to 531 in PKM1. By overlapping the structure of the protein 300 product of ENST000000561609 with PKM1, we found that the protein maintains well 301 defined ADP and PEP binding sites. However, the missing part constitutes part of the 302 C-C binding interface ( Figure 3B ). Therefore, whether the ENST000000561609 303 functions as a monomer or active tetramer needs further investigation. Comparing the 304 protein of ENST000000568883 with PKM1, we observed that it is missing large part of 305 both A and B domain as well as the whole N-terminal part. This led to a loss of a large 306 part in the ADP binding site and the binding interface, whereas the PEP binding site in 307 ENST000000568883 structure ( Figure 3B ) was kept. 308
309
As we have shown that the AA sequence of the protein products of 310 ENST00000561609, ENST00000389093 and ENST00000568883 resemble different 311 part of either PKM1 or PKM2, it is difficult to stratify them based on the AA sequence 312 only. However, we observed that all of these transcripts have different length of AA 313 sequences, and different protein masses. The protein masses for PKM1 and PKM2 314 are 58.1 kDa and 57.9 kDa, respectively, while the mass for protein products of 315 ENST00000561609, ENST00000389093 and ENST00000568883 are 53.0 kDa, 49.9 316 kDa and 40.2 kDa, respectively. Therefore, we separated these proteins based on their 317 mass differences using sodium dodecyl sulfate (SDS) gel electrophoresis and 318 evaluated them by Western blot. We used an antibody targeting the latter half of PKM2 319 for the detection of the other three transcripts since they shared a large portion of AA 320 sequence in those areas as shown in Figure 3A . We found that there are different 321 bands that appearing around 49 kDa and 40 kDa in the western blots ( Figure 3C ) in 322 three different human cell lines, which is in very good agreement with the putative mass 323 of protein products from ENST00000389093 and ENST00000568883, respectively. 324
We also found the two bands in the same location in the western blots of the nuclear 325 proteins, which means these two proteins may also play important roles in cell nucleus 326
we used three different siRNAs to inhibit the expression all protein isoforms of PKM. 333
As shown in Figure 3D , the cellular PKM level is decreased with the siRNA transferred 334 to the cells. In addition, we found the bands located at 49 kDa and 40 kDa also 335 significantly decreased. This indicated that the two bands we identified are encoded 336
by PKM. Moreover, we manually cut the gel with protein in PC3 from 37 kDa to 50 kDa 337 based on the marker and separated it into three horizontal slices. Subsequently, we 338 subjected the samples to enzymatic digestion and extracted peptides for analysis in 339 mass spectrometry (MS). Consequently, we detected signals of peptides on both the 340 top (49.9 kDa) and bottom (40.2 kDa) slices. As shown in Figure 3E , both of these 341 slices showed high MS intensity with good peptide coverage, proving that the bands 342 we identified are related to the corresponding transcripts. With respect to the one from 343 ENST00000561609, we could not visually separate the bands for PKM1 and PKM2 344 since they have a similar mass with PKM1 and PKM2. 345
346
The expression of prognostic transcripts in normal tissues and cancers 347
To further investigate the prevalence of the discovered proteins in different cancers, 348
we summarized the mRNA expression of the four transcripts as well as the transcript 349 for PKM1 in all cancers. As shown in Figure S2 , the three newly discovered prognostic 350 transcripts of PKM, including ENST00000561609, ENST00000389093 and 351 the functional role of transcripts in cancer progression. In this study, we performed a 373 transcript level analysis of PKM and found that four of them, including PKM2 but not 374 for PKM1, could play a key role in KIRC progression. We found that mRNA expression 375 of these four transcripts is also significantly associated with the survival of the patients 376 with different cancers. Next, we investigated the functional role of each transcript, 377 identified the associated biological functions and validated their prognostic effect in an 378 independent KIRC cohort. We also identified a signature to stratify patients with kidney 379 cancer into two groups with distinct biological features and survival. Finally, we 380 characterize for the first time the protein products of these key transcripts using 381
Western blots and mass spectrometry-based proteomics data and showed the 382 relevance of these transcripts in different normal tissues and cancer. 383
384
Previous studies reported that the ratio between PKM1 and PKM2 isoforms plays a 385 key role in cancer progression [34] [35] [36] [37] [38] . In our study, we found PKM1 is not strongly 386 associated with the survival of cancer patients as it has been reported 18 . Based on our 387 analysis, we observed that the disagreement between the studies may be explained 388 by the differences in transcriptomic quantification methods used in the analysis of the 389 data. For instance, a recent study quantified the mRNA level of PKM1 and PKM2 using 390
RT-PCR and reported their association in cancer 39 , but the primer they have used for 391
RT-PCR could also bind to ENST00000568883 and ENST00000561609. Thus, the 392 RNA level suggested for PKM1 transcript may actually be the sum of all three 393 transcripts rather than just PKM1. In addition, we also found that the RNA level of 394 PKM1 (<5%) is very low compared to PKM2 (~95%) which is in good agreement with 395 proteomics data reported earlier 40 , and it has the same magnitude as 396 ENST00000568883 and ENST00000561609 (Table S1 ). In this context, it is very likely 397 that ENST00000568883 or ENST00000561609 which showed prognostic effect in our 398 study may also play a key role in tumor metabolism. 399
400
We also showed the protein products of these two transcripts using Western blots and 401 validated their presence by MS after the identification of functional alternatively spliced 402 PKM transcripts. It is quite difficult to distinguish these transcripts and PKM2 since they 403 shared the majority of their nucleotide and AA sequences. For instance, the antibody 404 we used in this study is designed to specifically target the PKM2 protein, but it also 405 bound the protein products of ENST00000568883 and ENST00000389093. Therefore, 406 this might be a potential explanation for the contradicting prognostic effect related to 407 PKM2 in different studies, and there may be a need to revisit some of the previous 408 studies to investigate all isoforms of PKM. 409
410
In conclusion, we revealed the functional role of the three alternatively spliced PKM 411 transcripts in KIRC and different cancers based on an integrative systems analysis. 412
Our study may be considered as a primer for the future studies focusing on the 413 biological and oncological role of alternatively spliced gene transcripts of not only PKM 414 but also other gene targets. Such analysis may allow for the discovery of the right 415 protein product which could be effectively targeted using pharmaceutical agents. 416
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Materials and Methods 420
Data and preprocessing 421
The TCGA transcript-expression level profiles (TPM and count values) of 25 cancer-422 types with more than 100 patients and excluding LGG for the same reason as in our 423 previous study 3 
Survival analysis 438
Based on the TPM value of each transcript or gene, we classified the patients into two 439 groups and examined their prognoses. Survival curves were estimated by the Kaplan-440
Meier method and compared by log-rank test. To choose the best TPM cutoffs for 441 grouping the patients most significantly, all TPM values from the 10 th to 90 th percentiles 442 used to group the patients, significant differences in the survival outcomes of the two 443 groups were examined and the value yielding the lowest log-rank p value was selected. 444
445
For retrieving prognostic signature, we used the expression cutoff obtained in the 446 individual survival analysis for each of the four transcripts which could classify the 447 patients into two groups with significantly different prognoses. In TCGA cohort, if the 448 expression of ENST00000335181 or ENST00000561609 is less than 476.35 or 0.69 449 in a sample, this sample would be classified into high-risk group, otherwise, low-risk 450 group. On the other hand, if the expression value of ENST00000389093 or 451 ENST00000568883 is higher than 18.18 or 13.74 in a sample, this sample will be 452 classified into high-risk group, otherwise, low-risk group. Similarly, the cutoffs of the 453 four transcripts are 815.84, 0.33, 7.90 and 6.63 in Japanese cohort. Therefore, we 454 classified the samples of the two different cohorts into the high-risk group when at least 455 two transcripts are higher or lower than the corresponding cutoffs. 456
457
Differential expression analysis 458
DESeq2 45 was used to identify DEGs between two groups. The raw count values of 459 genes were used as input of DESeq2. The Benjamini-Hochberg procedure was used 460 to estimate FDR. 461 462
Overlapping of two lists of DEGs 463
If DEG list 1 with L1 genes and DEG list 2 with L2 genes have k overlapping genes, 464 among which s genes shows the same directions (up or down-regulation) in the two 465
DEGs lists, the probability of observing at least s consistent genes by chance can be 466 calculated according to the following cumulative hypergeometric distribution model: 467
where L represents the number of the background genes commonly detected in the 469 datasets from which the DEGs are extracted. The two DEG lists were considered to 470 be significantly overlapping if P < 0.05. 
Sample preparation for mass spectrometry analysis 507
The gel pieces were subjected to in-gel digestion as descried by Shevchenko, et al. 47 , 508 with some adjustments. Reduction was performed by addition of 10 mM dithiothreitol 509 and incubation at 56 °C for 30 min. The samples were alkylated by addition of 55 mM 510 2-chloroacetamide and incubation shielded from light for 20 min at room temperature. 511
Tryptic digestion was performed overnight at 37 °C after addition of trypsin solution 512 
Data analysis of LC-MS/MS results 541
The raw files obtained from the LC-MS/MS experiment were analyzed using MaxQuant 542 (version 1.6.1.0) 48 implementing Andromeda 49 to search the MS/MS data against the 543 Ensembl Homo sapiens database (version 83.38, all protein coding transcripts from 544 the primary assembly) as well as a separate database with the two distinct target 545 sequences (ENST00000389093 and ENST00000568883) a list of common 546 contaminants. Trypsin/P was used for cleavage specificity with up to two missed 547 cleavages. Oxidation (M) was used as a variable modification while 548 carbamidomethylation (C) was used as a fixed modification. The peptide and protein 549 FDR were set to 1% and the minimum peptide length was set to seven amino acids. 550
The presence of the target proteins was assessed by evaluating the identification of 551 unique peptides specific to the proteins in the different samples. 552
553
Homology model 554
The homology models were built using StructurePrediction panel in Schrödinger Suite 555 (Schrödinger, LLC, New York, NY). The ClustralW method was used to align the target 556 and template sequences in Prime, the energy-based was selected for model building 557 method, and homo-multimer was selected for multi-template model type. The 558 homology model of ENST00000561609 was built based on the PKM2 crystal structure 559 (PDB ID: 5X1W), as ENST00000561609 shares 96% sequence similarity to PKM2, 560 compare to 91% to PKM1. ENST00000389093 and ENST00000568883 share higher 561 sequence similarity to PKM1, with 100% and 92% correspondingly. These two 562 homology models were built based on the PKM1 crystal structure (PDB ID: 3SRF). 563 564 700  Table S1 . The average expression of PKM and its 14 transcripts in 25 cancer-types 701 Table S2 . Log-rank p value of PKM and its 14 transcripts in 25 cancer-types 702 Significantly enriched GO terms for each transcript are provided in Table S3 . 
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